Omapatrilat Reduces Pulse Pressure and Proximal Aortic Stiffness in Patients With Systolic Hypertension
- 25 June 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (25) , 2955-2961
Abstract
Background — Increased pulse pressure, an indicator of conduit vessel stiffness, is a strong independent predictor of cardiovascular events in hypertensive cohorts, which suggests that reduction of conduit vessel stiffness may be desirable in hypertension. Methods and Results — We assessed changes in pulse pressure and conduit vessel stiffness in a 12-week double-blind, randomized clinical trial that compared monotherapy with the ACE inhibitor enalapril 40 mg daily (n=87) versus the vasopeptidase (dual ACE and neutral endopeptidase) inhibitor omapatrilat 80 mg daily (n=80) in patients with systolic hypertension. Patients were withdrawn from antihypertensive medications 1 to 2 weeks before enrollment, and systolic pressure was confirmed to be ≥160 mm Hg. With the use of calibrated tonometry and pulsed Doppler, pulsatile hemodynamics were assessed before randomization and at 12 weeks. Characteristic impedance (Z c ), a direct measure of the stiffness of the central aorta, was calculated from the ratio of changes in carotid pressure and aortic flow in early systole. Omapatrilat compared with enalapril produced greater reductions in peripheral (−8.2±12.2 versus −4.0±12.2 mm Hg, P P c (237±83 to 208±70 versus 225±87 to 231±94 dyne · s/cm 5 , P P Conclusions — Greater reductions in pulse pressure and Z c in hypertensive subjects treated with omapatrilat compared with enalapril suggest that aortic stiffness is maintained by specific, partially reversible mechanisms and underscore a potential role for pharmacological modulation of natriuretic peptides in the treatment of hypertension.Keywords
This publication has 13 references indexed in Scilit:
- Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in ratsCardiovascular Research, 2001
- Endothelial Dysfunction, Hemodynamic Forces, and AtherogenesisaAnnals of the New York Academy of Sciences, 2000
- Pulse pressure, arterial compliance and cardiovascular morbidity and mortalityCurrent Opinion in Nephrology and Hypertension, 1999
- Natriuretic PeptidesNew England Journal of Medicine, 1998
- Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction.Hypertension, 1994
- Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjectsJACC, 1993
- Noninvasive determination of aortic input impedance and external left ventricular power output: A validation and repeatability study of a new techniqueJACC, 1992
- Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.Journal of Clinical Investigation, 1990
- Protection from atherosclerotic lesion formation by reduction of artery wall motionJournal of Vascular Surgery, 1987
- Forward and backward waves in the arterial systemCardiovascular Research, 1972